Compare Bristol-Myers Squibb Co (BMY) vs Goodyear Tire & Rubber Co (GT) Price & Performance

Bristol Myers Squibb (BMY) trades at $59.34, up 3.06% today, with a bullish technical signal and consistent earnings beats. The stock shows strong profitability with a 15.01% net margin and 38.84% ROE, though debt levels have risen. Recent FDA acceptance for mezigdomide in multiple myeloma highlights pipeline progress. Analysts are mixed with a $60 consensus target, slightly above current price.

BMY offers value with a P/E of 16.62 and a safe 4.3% dividend yield, but faces patent cliff risks and pricing pressures. Earnings growth and pipeline execution are key catalysts, while high debt and competitive threats require monitoring. The stock presents a balanced opportunity for income-focused investors with moderate risk tolerance.

Goodyear Tire & Rubber (GT) trades at $6.64, down 2.5% today, with a bearish technical signal and mixed quarterly earnings. The stock shows deep value metrics with a P/E of 4.69 and P/B of 0.64, but fundamental weakness persists with negative net income margin of -11.64% and ROE of -52.56%. Recent news includes a shift to the S&P SmallCap 600 and a $1.05 billion senior notes offering to strengthen liquidity.

The outlook remains challenging due to operational headwinds and declining revenue, though analyst consensus suggests 32% upside to the $8.75 price target. Key risks include sustained profitability issues and high debt, while potential catalysts include cost-saving initiatives and new contracts like NASA's lunar tire supply.